Intismeran
Personalized mRNA Cancer Vaccine Clears Phase 3 Test. Here’s What We Still Don’t Know
A personalized mRNA therapy improved recurrence-free and distant metastasis-free survival in a Phase 3 melanoma trial—but effect size and overall-survival data remain…